Raily Aesthetic Medicine International Holdings Limited (HK:2135)
:2135
Want to see HK:2135 full AI Analyst Report?
Total Valuation
Raily Aesthetic Medicine International Holdings Limited has a market cap or net worth of HK$75.21M. The enterprise value is HK$66.55M.
Market CapHK$75.21M
Enterprise ValueHK$66.55M
Share Statistics
Raily Aesthetic Medicine International Holdings Limited has 557,077,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding557,077,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Raily Aesthetic Medicine International Holdings Limited’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is -688.10%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)-688.10%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee636.24K
Profits Per Employee6.29K
Employee Count290
Asset Turnover0.78
Inventory Turnover15.36
Valuation Ratios
The current PE Ratio of Raily Aesthetic Medicine International Holdings Limited is 41.1. Raily Aesthetic Medicine International Holdings Limited’s PEG ratio is -0.41.
PE Ratio41.1
PS Ratio0.41
PB Ratio0.70
Price to Fair Value0.70
Price to FCF2.34
Price to Operating Cash Flow1.84
PEG Ratio-0.41
Income Statement
In the last 12 months, Raily Aesthetic Medicine International Holdings Limited had revenue of 184.51M and earned 1.82M in profits. Earnings per share was <0.01.
Revenue184.51M
Gross Profit75.70M
Operating Income5.05M
Pretax Income9.74K
Net Income1.82M
EBITDA26.97M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was 35.39M and capital expenditures -2.73M, giving a free cash flow of 32.66M billion.
Operating Cash Flow35.39M
Free Cash Flow32.66M
Free Cash Flow per Share0.06
Dividends & Yields
Raily Aesthetic Medicine International Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change18.42%
50-Day Moving Average0.14
200-Day Moving Average0.14
Relative Strength Index (RSI)41.95
Average Volume (3m)289.64K
Important Dates
Raily Aesthetic Medicine International Holdings Limited upcoming earnings date is Aug 21, 2026, TBA (Not Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateAug 21, 2026
Ex-Dividend Date―
Financial Position
Raily Aesthetic Medicine International Holdings Limited as a current ratio of 0.77, with Debt / Equity ratio of 54.86%
Current Ratio0.77
Quick Ratio0.71
Debt to Market Cap0.66
Net Debt to EBITDA0.05
Interest Coverage Ratio1.89
Taxes
In the past 12 months, Raily Aesthetic Medicine International Holdings Limited has paid 2.15M in taxes.
Income Tax2.15M
Effective Tax Rate220.73
Enterprise Valuation
Raily Aesthetic Medicine International Holdings Limited EV to EBITDA ratio is 2.83, with an EV/FCF ratio of 2.39.
EV to Sales0.41
EV to EBITDA2.83
EV to Free Cash Flow2.39
EV to Operating Cash Flow2.20
Balance Sheet
Raily Aesthetic Medicine International Holdings Limited has HK$57.82M in cash and marketable securities with HK$59.18M in debt, giving a net cash position of -HK$1.36M billion.
Cash & Marketable SecuritiesHK$57.82M
Total DebtHK$59.18M
Net Cash-HK$1.36M
Net Cash Per Share>-HK$0.01
Tangible Book Value Per ShareHK$0.09
Margins
Gross margin is 40.98%, with operating margin of 2.73%, and net profit margin of 0.99%.
Gross Margin40.98%
Operating Margin2.73%
Pretax Margin<0.01%
Net Profit Margin0.99%
EBITDA Margin14.62%
EBIT Margin2.73%
Analyst Forecast
The average price target for Raily Aesthetic Medicine International Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-4.86%
EPS Growth Forecast―